Protective effects of melatonin in experimental free radical-related ocular diseases. - Wikidata - wikimedia - TriplyDB

Protective effects of melatonin in experimental free radical-related ocular diseases.

Protective effects of melatonin in experimental free radical-related ocular diseases.

http://www.wikidata.org/entity/Q36379509

about

Protective role of melatonin in neonatal diseases Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration Expression and cellular localization of melatonin-synthesizing enzymes in the rat lens JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury Analytical tools for elucidating the biological role of melatonin in plants by LC-MS/MS.Melatonin Promotes the In Vitro Development of Microinjected Pronuclear Mouse Embryos via Its Anti-Oxidative and Anti-Apoptotic Effects.Profiling of oxidative stress in patients with inborn errors of metabolism.Melatonin combats molecular terrorism at the mitochondrial level.Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.Oxygen toxicity and reactive oxygen species: the devil is in the details.The Effect of Melatonin on Maturation, Glutathione Level and Expression of H MGB1 Gene in Brilliant Cresyl Blue (BCB) Stained Immature Oocyte Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes.Effects of melatonin on the nitric oxide system and protein nitration in the hypobaric hypoxic rat hippocampus.Therapeutic benefit of melatonin in refractory central serous chorioretinopathy No effect of exogenous melatonin on development of cryopreserved metaphase II oocytes in mouse cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants Diabetes Pathology and Risk of Primary Open-Angle Glaucoma: Evaluating Causal Mechanisms by Using Genetic Information.The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.Evidence supporting the use of melatonin in short gestation infants.Melatonin: potential functions in the oral cavity.Associations of sleep duration with open angle glaucoma in the Korea national health and nutrition examination survey.Melatonin and cancer: current knowledge and its application to oral cavity tumours.Emerging drugs for ocular hypertension.Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathy.Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway.Neuroprotective effect of melatonin in experimental optic neuritis in rats.Melatonin prevents nitric oxide-induced apoptosis by increasing the interaction between 14-3-3beta and p-Bad in SK-N-MC cells.Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.Therapeutic effect of melatonin in experimental uveitis.Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus.Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp.Ameliorative effects of melatonin against hydrogen peroxide-induced oxidative stress on boar sperm characteristics and subsequent in vitro embryo development.The role of melatonin as an antioxidant in human lens epithelial cells.Melatonin affects membrane integrity, intracellular reactive oxygen species, caspase3 activity and AKT phosphorylation in frozen thawed human sperm.Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment.Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin.Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress.

P2860

Q26861881-9E7BA80F-6E74-41B8-90CE-7013FA8D15A7 Q28078927-C8A52D11-3490-41BC-886F-2144B735B621 Q28566275-61B0B666-C912-45DA-9026-323E73C53C53 Q28581448-F7B6976B-F6EB-4ACF-A8E4-3185F8D98157 Q33458031-162ECD28-9C0C-433E-92E8-AEF471404540 Q33755049-D5127F69-521E-44FE-ADF6-4286508BD747 Q34043194-7D76EB11-AC9B-4FE7-AD1D-EC4E21D86536 Q34359618-99140DC5-11F4-4FFD-AA84-28BE4BA9D15C Q34914207-CAC4F06F-913D-457D-B6F4-B38690E63EA6 Q34977549-550F3A44-9E70-4B5F-82B6-B4C5F3802CBB Q35079344-D913AE29-4238-49A3-A34E-7151A4482B1B Q35166095-E66C3399-0A53-4CE6-AA50-EC7E0CAC8399 Q35800716-FE27A85D-FBCC-426A-B17D-56557CD0BEFC Q35970032-7F4F4920-6673-4987-9AB7-05AA5D88FFD0 Q36056545-BB635E92-4B2E-43FB-8D89-2B7B9D5C6C7E Q36197680-058C3079-1725-42ED-BD5A-D4BF4931F7EE Q36446283-45813EBC-2ED7-4E11-9A9F-EF285704A756 Q36696946-580FB890-C3B5-45DD-8539-9A4009B95B87 Q36696959-FF7A0BA8-04C0-4F3A-8F1A-EE8ADB3C4A58 Q36835794-116120B5-5B24-4F90-9EE1-23AD1643BC4B Q37552148-A9DA8F72-D291-4760-B369-203F7DB6EF89 Q37834066-5E469F59-DF01-4A58-9403-66C288D6C904 Q37847182-10297ED0-4FD4-4802-9BB1-62EF76DAEAC6 Q38031910-58BC65CF-C6BC-437E-9B9A-0941135DE47A Q38063946-BA443814-69A5-4702-8537-4421EA228FE4 Q38748509-874BED4A-9EE3-4286-AB7F-B4E73020BBD7 Q39993334-C4777445-5299-4F09-99CC-B3C9B214D959 Q40035877-041C9FB8-F024-4F8C-AA69-93539A235AD2 Q41455152-CFCB0658-72C6-4F91-9914-F450BE88191D Q41768470-97411BF1-2954-415E-B440-B1A28AE2B5A1 Q41895570-AB7FA4F3-318A-4CD6-A8CA-0EE12997B817 Q42749922-84071AF4-71F0-456A-9547-F2964C26D755 Q45079245-C4A65FAF-7A45-4062-8E37-CEE7F0071741 Q45994543-247003E4-E3B9-4FAA-ACDB-8FD78F518EEF Q46071712-5C9BCC6B-B280-4A0B-AAB5-E0716ACA557E Q46249638-80E73A8A-0EDD-4CBE-9756-902C4ADA5EE6 Q46703445-758D04E4-9A61-4C77-B6DB-B1ECBA1CB96B Q46703449-77866A25-1753-4DB6-8504-575D49D99CC3 Q46851658-44A27A2C-3E01-42BD-A6C8-90AF190681B7 Q46851688-A4239F23-30BF-4241-8833-6E3796E60BAB

P2860

Protective effects of melatonin in experimental free radical-related ocular diseases.

http://www.wikidata.org/entity/Q36379509

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Protective effects of melatonin in experimental free radical-related ocular diseases.

@ast

Protective effects of melatonin in experimental free radical-related ocular diseases.

@en

type

label

Protective effects of melatonin in experimental free radical-related ocular diseases.

@ast

Protective effects of melatonin in experimental free radical-related ocular diseases.

@en

prefLabel

Protective effects of melatonin in experimental free radical-related ocular diseases.

@ast

Protective effects of melatonin in experimental free radical-related ocular diseases.

@en

P1433

Q36379509-6A361C74-3A5B-406E-85CC-8328DCED3060

P1476

Q36379509-852D229A-3048-4466-AFD8-7A68828034D9

P2093

Q36379509-2266CF81-7AE6-4968-8E2F-23D0F4769E5A

P2860

Q36379509-019C62AC-8FAB-441F-84FC-48B971A1F291

Q36379509-01D04769-C961-42F9-9CBF-1AEBFC581AD4

Q36379509-0245B8E5-70B5-4A9C-B239-1AD5F76639A9

Q36379509-032C7CC4-6D3E-4A0F-A16D-955120B63A04

Q36379509-0ACE8D80-804F-478C-8513-B0B378139608

Q36379509-16FC33B9-DE90-4E6A-B3CE-995A13B85625

Q36379509-1876B911-D555-4281-ADB4-7671D82F9F31

Q36379509-1AB8907F-51D7-4EFE-8C56-FA1AD8A72A3B

Q36379509-1BCBE1E6-9BE9-4859-8304-75D8C50D6A8C

Q36379509-1F19F351-7DAC-4757-96BA-FDA09A32B475

P304

Q36379509-9094B205-E36B-4164-A806-398BE8F8BA09

P31

Q36379509-2172A608-6983-471A-BD4F-5E89DCC40CF4

P356

Q36379509-2CE7F55E-4E41-40A1-9973-78A0A7388039

P433

Q36379509-08B4F46C-38C3-41FE-8D60-AF3C5B77AE4E

P478

Q36379509-E51EC81B-DD0D-4BE9-818A-D3F8940AD1E0

P50

Q36379509-23A97864-8639-4659-8615-621025FB9CCB

Q36379509-6F0E7F72-1D86-4ADE-B0A0-B4E533869FA4

Q36379509-AC011B12-C85B-4D8D-8F5D-7DDF67204D3A

Q36379509-C85B277D-75DA-4DFD-AB85-916215015965

P577

Q36379509-E1EC58F5-37F2-469A-A598-07B74112C649

P5875

Q36379509-C8B739AF-F610-402E-821A-95AEA200D6C3

P698

Q36379509-183F5A83-C32A-4B50-9782-0075845F8C6D

P921

Q36379509-08D81859-D2CC-4C36-B482-A1EF09A4BD32

P356

J.1600-079X.2005.00304.X

P1433

Journal of Pineal Research

P1476

Protective effects of melatonin in experimental free radical-related ocular diseases

@en

P2093

Andrew W Siu

http://www.w3.org/2001/XMLSchema#string

P2860

Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease

Aging: a theory based on free radical and radiation chemistry

Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress

Circadian control of photoreceptor outer segment membrane turnover in mice genetically incapable of melatonin synthesis.

Fatty acid cytotoxicity to human lens epithelial cells.

3-hydroxykynurenine-mediated modification of human lens proteins: structure determination of a major modification using a monoclonal antibody.

Nitrosation of melatonin by nitric oxide and peroxynitrite.

Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.

Nitric oxide and mitochondrial respiration.

P304

101-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-079X.2005.00304.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Marina Sánchez-Hidalgo

Russel J Reiter

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7331249

http://www.w3.org/2001/XMLSchema#string

P698

16441546

http://www.w3.org/2001/XMLSchema#string

P921